19-35527197-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001166034.2(SBSN):c.1085G>A(p.Gly362Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000912 in 1,535,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001166034.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SBSN | NM_001166034.2 | c.1085G>A | p.Gly362Glu | missense_variant | 1/4 | ENST00000452271.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SBSN | ENST00000452271.7 | c.1085G>A | p.Gly362Glu | missense_variant | 1/4 | 1 | NM_001166034.2 | P2 | |
SBSN | ENST00000518157.1 | c.376-320G>A | intron_variant | 1 | A2 | ||||
SBSN | ENST00000588674.5 | c.315+710G>A | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151994Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000211 AC: 3AN: 142312Hom.: 0 AF XY: 0.0000263 AC XY: 2AN XY: 76066
GnomAD4 exome AF: 0.00000578 AC: 8AN: 1383846Hom.: 0 Cov.: 66 AF XY: 0.00000439 AC XY: 3AN XY: 682858
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151994Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74238
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.1085G>A (p.G362E) alteration is located in exon 1 (coding exon 1) of the SBSN gene. This alteration results from a G to A substitution at nucleotide position 1085, causing the glycine (G) at amino acid position 362 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at